Early Versus Late Hydration After Cesarean Section (CS)

NCT ID: NCT02630810

Last Updated: 2015-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

267 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the effect of early oral hydration on bowel movement after CS, it includes 2 groups: study group participants receive 100 ml water after 1hr from the end of CS, while the others receive water after 6hrs from the end of CS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Traditionally, oral intake after CS was depend on insurance of intestinal movement, since uncomplicated CS does not affect the intestine and the mother needs to care of her infants, lactates, discharged from hospital, early oral hydration may enhance bowel movement, so the investigators need to evaluate the safety of early oral hydration after CS.

This study compare the effects of introducing water during the 1st hour or after 6 hours on bowel movement after CS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Motility and Defaecation Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early oral hydration

Early oral intake of 100 ml clear unsweetened water 1 hour following the Cesarean Section, then upon patient's desire, then starting semisolid, solid food when participant passed flatus.

Group Type EXPERIMENTAL

Early oral hydration

Intervention Type OTHER

starting oral hydration 1 hour following Cesarean Section using 100 ml clear water

Delayed oral hydration

Oral intake of 100 ml clear unsweetened water after 6 hours from the end of CS then upon patient's request,then starting semisolid, solid food when participant passed flatus.

Group Type ACTIVE_COMPARATOR

Delayed oral hydration

Intervention Type OTHER

starting oral hydration 6 hours following Cesarean Section using 100 ml clear water

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early oral hydration

starting oral hydration 1 hour following Cesarean Section using 100 ml clear water

Intervention Type OTHER

Delayed oral hydration

starting oral hydration 6 hours following Cesarean Section using 100 ml clear water

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* uncomplicated elective or emergency lower segment Caesarean section
* average blood loss during and after cs
* regional anaesthesia
* primary or recurrent CS

Exclusion Criteria

* surgical complications esp; intestinal injury
* postpartum hemorrhage
* medical disorder with pregnancy eg. hypertension, diabetes mellitus
* factors that may increase risk of postpartum hemorrhage as twins pregnancy, polyhydramnios and anemia
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams Maternity Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AMR HELMY YEHIA

Lecturer in Obstetrics and Gynaecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amr Yehia, Lecturer

Role: PRINCIPAL_INVESTIGATOR

ainshams maternity hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams Maternity Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EVLHACS 1

Identifier Type: -

Identifier Source: org_study_id